| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9007883 | International Immunopharmacology | 2005 | 6 Pages |
Abstract
Leflunomide inhibits nitric oxide production in patients with active RA. Inhibition of NO synthesis may be one of the mechanisms responsible for the immunomodulatory activity of leflunomide.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
S. Vijaya Bhaskar Reddy, Ajay Wanchu, Madhu Khullar, S. Govindrajan, Pradeep Bambery,